We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

DCBY02 or DCSZ11 as a Monotherapy in Patients With Advanced or Metastatic Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05496595
Recruitment Status : Recruiting
First Posted : August 11, 2022
Last Update Posted : November 10, 2022
Sponsor:
Information provided by (Responsible Party):
DynamiCure Biotechnology

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 2024
Estimated Study Completion Date : October 2024